Breaking News

Fujifilm Invests in PhenoVista Biosciences

Investment aims to accelerate Development of New High-Content Screening Assay Services Using Differentiated iPSCs.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

FUJIFILM Corp. is investing in PhenoVista Biosciences, a contract research organization (CRO) and provider of custom and off-the-shelf imaging-based assay services based in San Diego, CA. Fujifilm and PhenoVista will accelerate the development of new high-content screening (HCS) assay services using FUJIFILM iCell® differentiated induced pluripotent stem cells (iPSCs) and PhenoVista’s cutting-edge imaging technologies. This investment is from the Life Sciences Corporate Venture Capital (LS-CVC) ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters